Enphase Energy Reports Financial Results for the Fourth Quarter and Fiscal Year 2016
Feb 28, 2017 21:05 pm UTC| Business
PETALUMA, Calif., Feb. 28, 2017 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced today financial results for the fourth quarter and year ended December31, 2016. Enphase Energy...
Ekso Bionics to Present at the 29th Annual Roth Conference
Feb 28, 2017 21:05 pm UTC| Business
RICHMOND, Calif., Feb. 28, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the company plans to participate in the 29th Annual Roth Conference in Orange County, CA. Ekso...
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results
Feb 28, 2017 21:05 pm UTC| Business
Key 2016 accomplishments include year-over-year increases in revenue of 25%, ClearPoint® procedures of 32% and disposable product revenue of 36% IRVINE, Calif., Feb. 28, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC)...
Feb 28, 2017 21:05 pm UTC| Business
SAN DIEGO, Feb. 28, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...
Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2017 Financial Results
Feb 28, 2017 21:05 pm UTC| Business
SANTA CLARA, Calif., Feb. 28, 2017 -- Ambarella, Inc. (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video compression and image processing semiconductors, today announced financial results for its...
Ocera to Present at the Cowen and Company 37th Annual Healthcare Conference
Feb 28, 2017 21:05 pm UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
Zafgen to Present at Upcoming Investor Conferences
Feb 28, 2017 21:05 pm UTC| Business
BOSTON, Feb. 28, 2017 -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases including type 2 diabetes and...